1. Market Research
  2. > Healthcare Market Trends
  3. > Healthcare Industry Analysis, August 2019 (p3)

Healthcare Industry Analysis, August 2019 (p3)

Customer Support

Talk to Veronica

+1 718 514 2762

Publication dates

  • All
    • Since 2019

Publishers

All regions

data types

  • All
    • Industry Data
61-90 of about 13000 reports

Hematology and Flow Cytometry 2019-2023: A Market Facing Regulatory and Competitive Challenges--Country Shares and Market Segment Forecasts for over 40 Tests--Technological Breakthroughs, Emerging Tests, Competitive Intelligence

Hematology and Flow Cytometry 2019-2023: A Market Facing Regulatory and Competitive Challenges--Country Shares and Market Segment Forecasts for over 40 Tests--Technological Breakthroughs, Emerging Tests, Competitive Intelligence

  • $ 14500
  • Industry report
  • August 2019

Hematology and Flow Cytometry 2019-2023: A Market Facing Regulatory and Competitive Challenges--Country Shares and Market Segment Forecasts for over 40 Tests--Technological Breakthroughs, Emerging Tests, ...

  • Industries : Diagnostics
  • Countries : World
Global Microbiology Analyzers and Consumables, 2019-2023: US, Europe, Japan--Market Share Analysis, Country Segment Forecasts, Competitive Intelligence, Technology Trends, Opportunities for Suppliers

Global Microbiology Analyzers and Consumables, 2019-2023: US, Europe, Japan--Market Share Analysis, Country Segment Forecasts, Competitive Intelligence, Technology Trends, Opportunities for Suppliers

  • $ 14500
  • Industry report
  • July 2019

Global Microbiology Analyzers and Consumables, 2019-2023: US, Europe, Japan--Market Share Analysis, Country Segment Forecasts, Competitive Intelligence, Technology Trends, Opportunities for SuppliersThis ...

  • Industries : Pathology
  • Countries : World, United States, Japan, Europe
Global Molecular Diagnostic Analyzers and Reagents, 2019-2023: US, Europe, Japan--Market Share Analysis, Country Segment Forecasts, Competitive Intelligence, Technology Trends, Opportunities for Suppliers

Global Molecular Diagnostic Analyzers and Reagents, 2019-2023: US, Europe, Japan--Market Share Analysis, Country Segment Forecasts, Competitive Intelligence, Technology Trends, Opportunities for Suppliers

  • $ 14500
  • Industry report
  • July 2019

Global Molecular Diagnostic Analyzers and Reagents, 2019-2023: US, Europe, Japan--Market Share Analysis, Country Segment Forecasts, Competitive Intelligence, Technology Trends, Opportunities for SuppliersThis ...

  • Industries : Diagnostics
  • Countries : Japan, United States, World, Europe
Europe Automated Microbiology Market for over 100 Tests

Europe Automated Microbiology Market for over 100 Tests

  • $ 12900
  • Industry report
  • September 2019

Europe Automated Microbiology Market for over 100 Tests: France, Germany, Italy, Spain, UKThis new report is a five-country strategic analysis of the major business opportunities emerging in the automated ...

  • Industries : Pathology
  • Countries : Europe, France, Germany, Italy, Spain, United Kingdom
Europe Virology and Bacteriology Market for over 100 Tests: France, Germany, Italy, Spain, UK--Supplier Shares and Strategies, Test Volume and Sales Segment Forecasts, Technology and Instrumentation Review

Europe Virology and Bacteriology Market for over 100 Tests: France, Germany, Italy, Spain, UK--Supplier Shares and Strategies, Test Volume and Sales Segment Forecasts, Technology and Instrumentation Review

  • $ 12800
  • Industry report
  • September 2019

Europe Virology and Bacteriology Market for over 100 Tests: France, Germany, Italy, Spain, UK--Supplier Shares and Strategies, Test Volume and Sales Segment Forecasts, Technology and Instrumentation ReviewThis ...

  • Industries : Pathology
  • Countries : Germany, Italy, Spain, Europe, France, United Kingdom
Europe Hemostasis Diagnostic Analyzers and Reagent Market for over 40 Tests: France, Germany, Italy, Spain, UK--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentation Review

Europe Hemostasis Diagnostic Analyzers and Reagent Market for over 40 Tests: France, Germany, Italy, Spain, UK--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentation Review

  • $ 12800
  • Industry report
  • September 2019

Europe Hemostasis Diagnostic Analyzers and Reagent Market for over 40 Tests: France, Germany, Italy, Spain, UK--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentation ...

  • Industries : Diagnostics
  • Countries : France, Germany, Italy, Spain, United Kingdom, Europe
Europe Transfusion Diagnostics Market for 40 Immunohematology and NAT Assays: France, Germany, Italy, Spain, UK--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation

Europe Transfusion Diagnostics Market for 40 Immunohematology and NAT Assays: France, Germany, Italy, Spain, UK--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation

  • $ 12800
  • Industry report
  • September 2019

Europe Transfusion Diagnostics Market for 40 Immunohematology and NAT Assays: France, Germany, Italy, Spain, UK--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies ...

  • Industries : Pathology
  • Countries : Europe, France, Germany, Italy, Spain, United Kingdom
Europe Infectious Disease Testing Market for Over 100 Tests: Emerging Opportunities in France, Germany, Italy, Spain, UK--Supplier Shares and Strategies, Test Volume and Sales Segment Forecasts, Technology and Instrumentation Review

Europe Infectious Disease Testing Market for Over 100 Tests: Emerging Opportunities in France, Germany, Italy, Spain, UK--Supplier Shares and Strategies, Test Volume and Sales Segment Forecasts, Technology and Instrumentation Review

  • $ 12800
  • Industry report
  • August 2019

Europe Infectious Disease Testing Market for Over 100 Tests: Emerging Opportunities in France, Germany, Italy, Spain, UK--Supplier Shares and Strategies, Test Volume and Sales Segment Forecasts, Technology ...

  • Industries : Pathology
  • Countries : Germany, Italy, Spain, Europe, France, United Kingdom
Europe Cancer Diagnostics Market Analysis: Emerging Opportunities in France, Germany, Italy, Spain, UK--Supplier Shares and Strategies, Latest Tumor Markers, Volume and Sales Segment Forecasts, Technology and Instrumentation

Europe Cancer Diagnostics Market Analysis: Emerging Opportunities in France, Germany, Italy, Spain, UK--Supplier Shares and Strategies, Latest Tumor Markers, Volume and Sales Segment Forecasts, Technology and Instrumentation

  • $ 12800
  • Industry report
  • August 2019

Europe Cancer Diagnostics Market Analysis: Emerging Opportunities in France, Germany, Italy, Spain, UK--Supplier Shares and Strategies, Latest Tumor Markers, Volume and Sales Segment Forecasts, Technology ...

  • Industries : Medical Biotechnology
  • Countries : Europe, France, Germany, Italy, Spain, United Kingdom, World
Europe Hemostasis Analyzers and Reagents Market, 2019-2023: Supplier Shares and Sales Forecasts by Product and Country--France, Germany, Italy, Spain, UK--Competitive Intelligence, Technology and Instrumentation Review, Opportunities for Suppliers

Europe Hemostasis Analyzers and Reagents Market, 2019-2023: Supplier Shares and Sales Forecasts by Product and Country--France, Germany, Italy, Spain, UK--Competitive Intelligence, Technology and Instrumentation Review, Opportunities for Suppliers

  • $ 12800
  • Industry report
  • July 2019

Europe Hemostasis Analyzers and Reagents Market, 2019-2023: Supplier Shares and Sales Forecasts by Product and Country--France, Germany, Italy, Spain, UK--Competitive Intelligence, Technology and Instrumentation ...

  • Industries : Diagnostics
  • Countries : Germany, Italy, Spain, Europe, France, United Kingdom
Europe Microbiology Analyzers and Reagents Market, 2019-2023: Supplier Shares and Sales Segment Forecasts by Product--France, Germany, Italy, Spain, UK--Competitive Intelligence, Technology and Instrumentation Review, Opportunities for Suppliers

Europe Microbiology Analyzers and Reagents Market, 2019-2023: Supplier Shares and Sales Segment Forecasts by Product--France, Germany, Italy, Spain, UK--Competitive Intelligence, Technology and Instrumentation Review, Opportunities for Suppliers

  • $ 12800
  • Industry report
  • July 2019

Europe Microbiology Analyzers and Reagents Market, 2019-2023: Supplier Shares and Sales Segment Forecasts by Product--France, Germany, Italy, Spain, UK--Competitive Intelligence, Technology and Instrumentation ...

  • Industries : Pathology
  • Countries : Germany, Italy, Spain, Europe, France, United Kingdom
Europe NAT/Nucleic Acid Testing Analyzers and Reagents Market, 2019-2023: Supplier Shares and Sales Segment Forecasts by Product

Europe NAT/Nucleic Acid Testing Analyzers and Reagents Market, 2019-2023: Supplier Shares and Sales Segment Forecasts by Product

  • $ 12800
  • Industry report
  • July 2019

Europe NAT/Nucleic Acid Testing Analyzers and Reagents Market, 2019-2023: Supplier Shares and Sales Segment Forecasts by Product--France, Germany, Italy, Spain, UK--Competitive Intelligence, Technology ...

  • Industries : In Vitro Diagnostics, In Vitro Diagnostics, Diagnostics
  • Countries : Europe, France, Germany, Italy, Spain, United Kingdom
Infectious Disease Molecular Diagnostics Market: US, Europe, Japan--Suppliers Shares and Sales Segment Forecasts by Test, Emerging Technologies, Competitive Landscape

Infectious Disease Molecular Diagnostics Market: US, Europe, Japan--Suppliers Shares and Sales Segment Forecasts by Test, Emerging Technologies, Competitive Landscape

  • $ 12500
  • Industry report
  • August 2019

Infectious Disease Molecular Diagnostics Market: US, Europe, Japan--Suppliers Shares and Sales Segment Forecasts by Test, Emerging Technologies, Competitive LandscapeThis new seven-country study contains ...

  • Industries : Diagnostics
  • Countries : United States, Europe, Japan
POC/Point-of-Care Diagnostic Testing Market, 2019-2023: Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts for 300 Tests, Technology Trends, Instrumentation Review

POC/Point-of-Care Diagnostic Testing Market, 2019-2023: Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts for 300 Tests, Technology Trends, Instrumentation Review

  • $ 12500
  • Industry report
  • July 2019

POC/Point-of-Care Diagnostic Testing Market, 2019-2023: Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts for 300 Tests, Technology Trends, Instrumentation ReviewVPGMarketResearch’s ...

  • Industries : Pathology, Diagnostics, Therapy
Global Infectious Disease Testing Market, 2019-2023: Sales and Market Shares of Major Suppliers by Test and Country--US, Europe, Japan

Global Infectious Disease Testing Market, 2019-2023: Sales and Market Shares of Major Suppliers by Test and Country--US, Europe, Japan

  • $ 11500
  • Industry report
  • July 2019

Global Infectious Disease Testing Market, 2019-2023: Sales and Market Shares of Major Suppliers by Test and Country--US, Europe, JapanThis unique report from VPGMarketResearch provides sales and market ...

  • Industries : Diagnostics
  • Countries : United States, France, Japan, Germany, Spain, Italy
Cyramza

Cyramza

  • $ 10000
  • Industry report
  • September 2019

Drug OverviewCyramza (ramucirumab; Eli Lilly) is a fully human vascular endothelial growth factor receptor (VEGFR)-2-directed immunoglobulin G1 monoclonal antibody that binds to the extracellular domain ...

  • Industries : Cancer, Pathology
  • Countries : United States, Japan, European Union
Nexavar

Nexavar

  • $ 10000
  • Industry report
  • September 2019

Drug OverviewNexavar (sorafenib; Bayer/Amgen) is an orally available, multi-targeted tyrosine kinase inhibitor that is directed against several targets, including CRAF, BRAF, RET, KIT, FMS-like tyrosine ...

  • Industries : Pathology, Cancer, Therapy
  • Countries : United States, Japan, European Union
Tecentriq

Tecentriq

  • $ 10000
  • Industry report
  • September 2019

Drug OverviewTecentriq (atezolizumab; Roche/Chugai) is a fully humanized monoclonal antibody that targets programmed death-ligand 1 (PD-L1). PD-L1 is expressed on the surface of antigen-presenting cells ...

  • Industries : Cancer, Pathology
  • Countries : United States, European Union
Opdivo

Opdivo

  • $ 10000
  • Industry report
  • September 2019

Drug OverviewOpdivo (nivolumab; Bristol-Myers Squibb/Ono Pharmaceutical) is a fully human immunoglobulin G4 PD-1 immune checkpoint inhibitor that binds to the checkpoint receptor PD-1 expressed on activated ...

  • Industries : Cancer, Pathology
  • Countries : United States, European Union, Japan
tislelizumab

tislelizumab

  • $ 10000
  • Industry report
  • September 2019

Drug OverviewTislelizumab (BeiGene) is a humanized monoclonal antibody that was designed to bind to the PD-1 receptor and prevent binding of PD-L1. In addition, tislelizumab was designed to minimize binding ...

  • Industries : Pathology, Medical Biotechnology
  • Countries : United States
Lenvima

Lenvima

  • $ 10000
  • Industry report
  • September 2019

Drug OverviewLenvima (lenvatinib; Eisai/Merck and Co) is an orally available small molecule inhibitor of multiple tyrosine kinases, including vascular endothelial growth factor receptor (VEGFR), platelet-derived ...

  • Industries : Pathology, Cancer
  • Countries : United States, Japan, European Union
Keytruda

Keytruda

  • $ 10000
  • Industry report
  • September 2019

Drug OverviewKeytruda (pembrolizumab; Merck and Co) is a humanized monoclonal antibody designed to inhibit the PD-1 co-inhibitory receptor. The interaction between PD-1 and its primary ligand, PD-L1, inhibits ...

  • Industries : Cancer, Pathology
  • Countries : United States, Japan, European Union
Stivarga

Stivarga

  • $ 10000
  • Industry report
  • September 2019

Drug OverviewStivarga (regorafenib; Bayer/Amgen) is an orally available small molecule inhibitor that is currently approved for the treatment of previously treated hepatocellular carcinoma patients. It ...

  • Industries : Pathology, Cancer
  • Countries : United States, Japan, European Union
Cabometyx

Cabometyx

  • $ 10000
  • Industry report
  • September 2019

Drug OverviewCabometyx (cabozantinib; Exelixis/Ipsen/Takeda) is an orally available small molecule inhibitor which has been shown to suppress tumor growth and metastasis by inhibiting the activity of multiple ...

  • Industries : Pathology, Cancer
  • Countries : United States, Japan, European Union
Imfinzi

Imfinzi

  • $ 10000
  • Industry report
  • September 2019

Drug OverviewImfinzi (durvalumab; AstraZeneca) is a human monoclonal antibody directed against programmed death-ligand 1 (PD-L1). The interaction between PD-L1 and its receptor, programmed death-1 (PD-1), ...

  • Industries : Pathology, Cancer
  • Countries : European Union, Japan, United States
Menveo

Menveo

  • $ 10000
  • Industry report
  • September 2019

Drug OverviewMenveo (quadrivalent oligosaccharide diphtheria CRM-197 conjugate vaccine; GlaxoSmithKline) is a quadrivalent meningococcal glycoconjugate vaccine that uses CRM-197, a natural mutant of the ...

  • Industries : Therapy, Pathology
  • Countries : United States, European Union
Nimenrix

Nimenrix

  • $ 10000
  • Industry report
  • September 2019

Drug OverviewNimenrix (quadrivalent polysaccharide tetanus toxoid conjugate vaccine; Pfizer) is a conjugated polysaccharide vaccine indicated for active immunization to prevent invasive meningococcal disease ...

  • Industries : Therapy, Pathology
  • Countries : European Union, Europe
Menactra

Menactra

  • $ 10000
  • Industry report
  • September 2019

Drug OverviewMenactra (Sanofi) is a quadrivalent polysaccharide diphtheria toxoid conjugate vaccine indicated for active immunization to prevent invasive meningococcal disease (IMD) caused by Neisseria ...

  • Industries : Therapy, Pathology
  • Countries : United States
Trumenba

Trumenba

  • $ 10000
  • Industry report
  • September 2019

Drug OverviewTrumenba (Pfizer) is a bivalent recombinant meningococcal serogroup B vaccine indicated for immunization to prevent invasive meningococcal disease (IMD) caused by Neisseria meningitidis serogroup ...

  • Industries : Pathology
  • Countries : United States
Bexsero

Bexsero

  • $ 10000
  • Industry report
  • September 2019

Drug OverviewBexsero (multicomponent meningococcal serogroup B vaccine; GlaxoSmithKline) is a multicomponent meningococcal serogroup B vaccine. It is approved for the prevention of invasive meningococcal ...

  • Industries : Therapy, Pathology, Medical Biotechnology, Pharmaceutical
  • Countries : United States, European Union
About 18000 reports

Download Unlimited Documents from Trusted Public Sources

Healthcare Industry in Canada - Forecast

  • October 2019
    30 pages
  • Healthcare  

    Health Services  

    Nursing Home  

  • Canada  

    North America  

View report >

HIV AIDS Statistics October 2019


Reportlinker.com © Copyright 2019. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on